Cholesterol-lowering drug Lipitor reduces mortality in study

08/29/2011 | CNN/The Chart blog

A follow-up study in the European Heart Journal found that patients taking Pfizer's cholesterol-lowering statin Lipitor had a 14% lower death rate compared with placebo users. The finding was attributed mainly to a significant reduction in mortality from respiratory and infectious diseases. A clinical trial of Lipitor ended in 2003 after the statin demonstrated effectiveness in preventing stroke and heart attack.

View Full Article in:

CNN/The Chart blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA